Elsevier

The Lancet

Volume 319, Issue 8267, 6 February 1982, Pages 308-310
The Lancet

PLASMA ALKALINE PHOSPHATASE ACTIVITY: A SCREENING TEST FOR RICKETS IN PRETERM NEONATES

https://doi.org/10.1016/S0140-6736(82)91569-0Get rights and content

Abstract

Both rickets and raised plasma alkaline phosphatase activity are common in the preterm infant. Measurement of plasma alkaline phosphatase activity is valuable in screening for active disease and in diagnosis, but normal reference data are not available for preterm babies. In 30 consecutive preterm infants (birthweight 1580±410 g, gestational age 31±2·5 weeks) serial measurements of plasma alkaline phosphatase activity, plasma levels of calcium and inorganic phosphorus, and the pattern of alkaline phosphatase isoenzymes were made. Four patterns of changes in plasma alkaline phosphatase activity with time were seen. 4 of the 30 infants were shown to have rickets; these children and 14 of the 26 non-rachitic infants showed an increasing/peak/decreasing pattern with increasing age, but levels were much higher in the rachitic infants. The activity in all 30 was raised above the adult and childhood reference ranges at some point in time. The data suggest that an activity of five times the upper limit of the normal adult reference range is acceptable in the preterm infant but an activity higher than this may suggest rickets.

References (14)

There are more references available in the full text version of this article.

Cited by (65)

  • Screening for Metabolic Bone Disease of prematurity

    2020, Seminars in Fetal and Neonatal Medicine
    Citation Excerpt :

    In 1982, Kovar et al. first introduced the use of serum ALP as a biomarker to test for rickets in preterm infants and suggested a cutoff of five times the upper limit of the normal range in adults (>1650 U/L). This was based on the serum ALP levels of four of 30 infants who had radiologic evidence of rickets [11,12]. In 1982, Koo et al. also reported correlations between decreased skeletal demineralization on X-rays and elevated ALP level, decreased birth weight, decreased gestational age, and decreased enteral feeds.

  • Metabolic bone disease in preterm infants: Relationship between radiologic grading in the wrist and serum biochemical markers

    2017, Diagnostic and Interventional Imaging
    Citation Excerpt :

    In our study, 29 of 34 (85.2%) ELBW infants showed an abnormal wrist radiography, and 4 of 29 (11.7%) showed grade 3 (fractures). The levels of ALP and P are the most commonly used biochemical markers for the detection of MBD [6,8,12,13]; however, there is no clear cut-off value reported for an accurate diagnosis of MBD [14,15]. Rustico et al. [16] showed that only the serum ALP level was increased in a fracture group compared to an osteopenia group, and there were no significant differences in serum P, calcium, or parathyroid hormone (PTH) levels.

  • The effects of maternal iron deficiency on infant fibroblast growth factor-23 and mineral metabolism

    2016, Bone
    Citation Excerpt :

    In addition TALP was also higher in LI from 24 wk of age compared to the NI group. TALP when elevated is a marker of metabolic bone disease and is elevated in children with rickets [23]. The increased TALP concentrations in the LI group may be indicating that poor iron status has a negative influence on bone health, possibly mediated through its association with elevated FGF23 production.

  • Detecting rickets in premature infants and treating them with calcitriol: Experience from two cases

    2012, Kaohsiung Journal of Medical Sciences
    Citation Excerpt :

    Koo et al. [14] reported correlations between the presence of skeletal demineralization and birth weight, gestational age, enteral feeding, and elevated serum ALP levels. Kovar et al. [15] suggest that an ALP activity that is five times higher than the upper limit of the normal adult reference range is acceptable in preterm infants, but an activity higher than this may suggest rickets. In addition, the male sex is also a risk factor of rickets.

  • Bone disease of prematurity

    2007, Early Human Development
View all citing articles on Scopus
View full text